Asker Healthcare Group AB (publ) (STO:ASKER)
59.35
-0.65 (-1.08%)
Sep 18, 2026, 5:29 PM CET
Asker Healthcare Group AB Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Asker Healthcare Group AB stock has a consensus rating of "Buy" and an average price target of kr 88.40. The average 1-year stock price forecast is 48.95% higher than the current stock price, while the lowest is kr 60.00 (+1.10%) and the highest is kr 105.00 (+76.92%).
Price Target: kr 88.40 (+48.95%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Mar 27, 2026.
Analyst Ratings
The average analyst rating for Asker Healthcare Group AB stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citi No rating | Citi | Buy Maintains kr 120.00 → kr 100.00 | Buy | Maintains | kr 120.00 → kr 100.00 | +68.49% | Mar 27, 2026 |
Financial Forecast
Revenue This Year
19.12B
from 16.79B
Increased by 13.92%
Revenue Next Year
20.68B
from 19.12B
Increased by 8.14%
EPS This Year
2.94
from 1.76
Increased by 66.33%
EPS Next Year
3.38
from 2.94
Increased by 15.20%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.